# Reinsurance Group of America Inc: overview

RGA · NYSE · CIK 898174 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rga.md) · [Financials](/companies/rga/financials.md) · [Filings](/companies/rga/filings.md) · [Insiders](/companies/rga/insiders.md)

Latest reported revenue: [$6.64bn](/filings/0000898174-26-000034.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:Revenues, accession 0000898174-26-000034).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,651](/filings/0000898174-26-000006.md) | [5,241](/filings/0000898174-26-000006.md) | [5,260](/filings/0000898174-26-000025.md) | [5,599](/filings/0000898174-26-000034.md) | [6,204](/filings/0000898174-26-000006.md) | [6,635](/filings/0000898174-26-000006.md) | [6,494](/filings/0000898174-26-000025.md) | [6,637](/filings/0000898174-26-000034.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [2.8%](/filings/0000898174-25-000137.md) | [2.9%](/filings/0000898174-26-000006.md) | [5.4%](/filings/0000898174-26-000025.md) | [3.2%](/filings/0000898174-26-000034.md) | [4.1%](/filings/0000898174-25-000137.md) | [7.0%](/filings/0000898174-26-000006.md) | [5.1%](/filings/0000898174-26-000025.md) | [7.0%](/filings/0000898174-26-000034.md) |
| Diluted EPS | $ per share | [2.33](/filings/0000898174-26-000006.md) | [2.22](/filings/0000898174-26-000006.md) | [4.27](/filings/0000898174-26-000025.md) | [2.70](/filings/0000898174-26-000034.md) | [3.81](/filings/0000898174-26-000006.md) | [6.97](/filings/0000898174-26-000006.md) | [4.98](/filings/0000898174-26-000025.md) | [7.01](/filings/0000898174-26-000034.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:ProfitLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [16.7](/filings/0000898174-24-000048.md) | [16.2](/filings/0000898174-25-000027.md) | [18.6](/filings/0000898174-26-000006.md) | [22.1](/filings/0000898174-26-000006.md) | [23.7](/filings/0000898174-26-000006.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [7.0%](/filings/0000898174-24-000048.md) | [3.2%](/filings/0000898174-25-000027.md) | [4.9%](/filings/0000898174-26-000006.md) | [3.2%](/filings/0000898174-26-000006.md) | [5.0%](/filings/0000898174-26-000006.md) |
| Diluted EPS | $ per share | [17.13](/filings/0000898174-24-000048.md) | [7.64](/filings/0000898174-25-000027.md) | [13.44](/filings/0000898174-26-000006.md) | [10.73](/filings/0000898174-26-000006.md) | [17.69](/filings/0000898174-26-000006.md) |
| Free cash flow | $bn | [4.2](/filings/0000898174-24-000048.md) | [1.3](/filings/0000898174-25-000027.md) | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/rga/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.45bn | 6,810,718 |  | Added +131,403 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $1.26bn | 5,923,875 |  | Reduced −2,985 |
| [HARRIS ASSOCIATES L P](/funds/813917.md) | 2026-06-30 | $996.1m | 4,684,424 |  | Reduced −166,054 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $742.9m | 3,493,339 |  | Reduced −10,859 |
| [WCM INVESTMENT MANAGEMENT, LLC](/funds/1061186.md) | 2026-06-30 | $646.0m | 3,007,065 |  | Added +176,445 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $629.7m | 2,961,322 |  | Added +23,027 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $501.5m | 2,358,429 |  | Added +89,226 |
| [EARNEST PARTNERS LLC](/funds/1102578.md) | 2026-06-30 | $471.9m | 2,219,193 |  | Reduced −47,468 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $323.6m | 1,521,592 |  | Reduced −303,790 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $301.0m | 1,415,016 |  | Added +13,696 |

## Recent filings

[All 1,380 filings](/companies/rga/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-07 | 18:25 ET | [10-Q](/filings/0000898174-26-000034.md) | Quarterly report, period 2026-06-30 | 0000898174-26-000034 |
| 2026-08-06 | 20:19 ET | [8-K](/filings/0000898174-26-000030.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000898174-26-000030 |
| 2026-07-09 | 21:07 ET | [8-K](/filings/0001193125-26-299825.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-299825 |
| 2026-07-01 | 21:18 ET | [8-K](/filings/0001193125-26-292830.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-292830 |
| 2026-06-22 | 13:02 ET | [8-K](/filings/0001193125-26-276808.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-276808 |
| 2026-05-21 | 20:16 ET | [8-K](/filings/0001193125-26-234445.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-234445 |
| 2026-05-08 | 17:51 ET | [10-Q](/filings/0000898174-26-000025.md) | Quarterly report, period 2026-03-31 | 0000898174-26-000025 |
| 2026-05-07 | 20:20 ET | [8-K](/filings/0000898174-26-000022.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000898174-26-000022 |
| 2026-05-01 | 20:22 ET | [8-K](/filings/0001193125-26-201509.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-201509 |
| 2026-04-09 | 20:07 ET | [DEF 14A](/filings/0000898174-26-000017.md) | Proxy statement, period 2026-05-20 | 0000898174-26-000017 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000898174-26-000006.md), filed Feb 20, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/4e986f85-8aa6-47bf-bee4-5295d6177df2)

## About the filer

- CIK: 898174
- Tickers: RGA, RZC
- Exchange: NYSE
- SIC code: 6311 Life Insurance
- State of incorporation: MO
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.